Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09)Nizar M. Tannir, Oleg Karyakin, Aleksandr Vasiliev et al.|Journal of Clinical Oncology|2024Cited by 26
A Phase 2/3, Randomized, Double Blind, Placebo-Controlled, Multicenter Study of NKTR-255 Vs Placebo Following CD-19 Directed CAR-T Therapy in Patients with Relapsed/Refractory Large B-Cell LymphomaMiguel‐Angel Perales, Cameron J. Turtle, Sairah Ahmed et al.|Blood|2022Cited by 1